Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000185874 | SCV000238826 | benign | not specified | 2014-07-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ce |
RCV000658852 | SCV000780649 | uncertain significance | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | ETFB: PM2, BP4 |
Labcorp Genetics |
RCV001086047 | SCV001013135 | likely benign | Multiple acyl-CoA dehydrogenase deficiency | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Cavalleri Lab, |
RCV001171332 | SCV001328279 | uncertain significance | Chronic kidney disease | 2020-05-28 | criteria provided, single submitter | research | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000185874 | SCV004813892 | likely benign | not specified | 2024-02-08 | criteria provided, single submitter | clinical testing | Variant summary: ETFB c.292C>T (p.Arg98Cys) results in a non-conservative amino acid change located in the Electron transfer flavoprotein, alpha/beta-subunit, N-terminal (IPR014730) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0014 in 251232 control chromosomes in the gnomAD database, including 1 homozygotes. The observed variant frequency is approximately 1 fold of the estimated maximal expected allele frequency for a pathogenic variant in ETFB causing Glutaric Aciduria, Type 2b phenotype (0.0011), strongly suggesting that the variant is benign. c.292C>T has been reported in the literature in an individual affected with mitochondrial disorders (DaRe_2013), without strong evidence for causality. These report(s) do not provide unequivocal conclusions about association of the variant with Glutaric Aciduria, Type 2b. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 24215330). ClinVar contains an entry for this variant (Variation ID: 203697). Based on the evidence outlined above, the variant was classified as likely benign. |
Prevention |
RCV003907648 | SCV004719220 | likely benign | ETFB-related disorder | 2020-01-08 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |